These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11786977)

  • 21. Yellow fever 5' noncoding region as a potential element to improve hepatitis C virus production through modification of translational control.
    Malet I; Wychowski C; Huraux JM; Agut H; Cahour A
    Biochem Biophys Res Commun; 1998 Dec; 253(2):257-64. PubMed ID: 9878525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
    McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
    Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the interferon alpha response against hepatitis C virus replicons.
    Guo JT; Sohn JA; Zhu Q; Seeger C
    Virology; 2004 Jul; 325(1):71-81. PubMed ID: 15231387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric assay using two fluorescent proteins for the function of the internal ribosome entry site of hepatitis C virus.
    Shi G; Yagyu F; Shimizu Y; Shimizu K; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
    Cytometry A; 2011 Aug; 79(8):653-60. PubMed ID: 21710641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of RUNX2 isoforms: involvement of cap-dependent and cap-independent mechanisms of translation.
    Elango N; Li Y; Shivshankar P; Katz MS
    J Cell Biochem; 2006 Nov; 99(4):1108-21. PubMed ID: 16767703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
    Li D; Lott WB; Martyn J; Haqshenas G; Gowans EJ
    J Virol; 2004 Nov; 78(21):12075-81. PubMed ID: 15479850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autogenous translational inhibition of core protein: implication for switch from translation to RNA replication in hepatitis C virus.
    Zhang J; Yamada O; Yoshida H; Iwai T; Araki H
    Virology; 2002 Feb; 293(1):141-50. PubMed ID: 11853407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA.
    Mondal T; Ray U; Manna AK; Gupta R; Roy S; Das S
    J Virol; 2008 Dec; 82(23):11927-38. PubMed ID: 18829760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site.
    Takyar SS; Gowans EJ; Lott WB
    J Mol Biol; 2002 May; 319(1):1-8. PubMed ID: 12051931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hepatitis C virus IRES-mediated translation by oligonucleotides.
    Li X; Mueller S; Wimmer E
    Virus Res; 2009 Dec; 146(1-2):29-35. PubMed ID: 19720092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of AUG codons in the hepatitis C virus 5' nontranslated region on translation and mapping of the translation initiation window.
    Rijnbrand RC; Abbink TE; Haasnoot PC; Spaan WJ; Bredenbeek PJ
    Virology; 1996 Dec; 226(1):47-56. PubMed ID: 8941321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domains I and II in the 5' nontranslated region of the HCV genome are required for RNA replication.
    Kim YK; Kim CS; Lee SH; Jang SK
    Biochem Biophys Res Commun; 2002 Jan; 290(1):105-12. PubMed ID: 11779140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation.
    Ali N; Pruijn GJ; Kenan DJ; Keene JD; Siddiqui A
    J Biol Chem; 2000 Sep; 275(36):27531-40. PubMed ID: 10856291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of translation initiation on hepatitis C virus RNA.
    Nomoto A; Tsukiyama-Kohara K; Kohara M
    Princess Takamatsu Symp; 1995; 25():111-9. PubMed ID: 8875615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathway of HCV IRES-mediated translation initiation.
    Otto GA; Puglisi JD
    Cell; 2004 Oct; 119(3):369-80. PubMed ID: 15507208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA.
    Ji H; Fraser CS; Yu Y; Leary J; Doudna JA
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):16990-5. PubMed ID: 15563596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.
    Lerat H; Shimizu YK; Lemon SM
    J Virol; 2000 Aug; 74(15):7024-31. PubMed ID: 10888641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting hepatitis C virus translation: stopping HCV where it starts.
    Jubin R
    Curr Opin Investig Drugs; 2003 Feb; 4(2):162-7. PubMed ID: 12669376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
    Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
    PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.